We then compared FGFR2 expression and activation in NCI-H716 cells relative to a panel of nine colorectal cancer cell lines without FGFR2 amplification, and we found striking FGFR2 overexpression and phosphorylation only in NCI-H716 cells (Figure 1B). This evidence concerns the gene FGFR2 and colorectal cancer.